Clinical Trial Update: How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

View source ↗

Summary

This clinical trial update discusses how gut microbes and metabolism may predict responses to skin cancer immunotherapy, though the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Melanoma
• Merkel Cell Carcinoma
• Skin Cancer
• Squamous Cell Carcinoma of the Skin

Snippet

Sponsor: Washington University School of Medicine | Conditions: Autoimmunity, Melanoma | Status: TERMINATED